Esperion Therapeutics (ESPR) PT Lowered to $15 at Cowen
Tweet
Share
E-mailGet Alerts ESPR Hot Sheet
Price: $3.18 --0%
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 46
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 46
Join SI Premium – FREE
Cowen analyst Joseph Thome lowered the price target on Esperion Therapeutics (NASDAQ: ESPR) to $15.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Travere Therapeutics (TVTX) PT Raised to $89 at Guggenheim
- Okta, Inc (OKTA) PT Raised to $240 at Jefferies
- Cracker Barrel (CBRL) PT Raised to $48 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
